Naiara Perurena

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Sentinel Lymph Node

Prognostic Factors

Top Venues

Nature reviews. Cancer

Cancer discovery

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Loi, Amy E Schade, Carrie L Rodriguez, Anjana Krishnan, Naiara Perurena, Van T M Nguyen, Yilin Xu, Marina Watanabe, Rachel A Davis, Alycia Gardner, Natalie F Pilla, Kaia Mattioli, Olesja Popow, Nuray Gunduz, Tamsin R M Lannagan, Samantha Fitzgerald, Ewa T Sicinska, Jia-Ren Lin, William Tan, Lauren K Brais, Kevin M Haigis, Marios Giannakis, Kimmie Ng, Sandro Santagata, Kristian Helin, Owen James Sansom, Karen Cichowski
Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers. Cancer discovery (2024)
Naiara Perurena, Lisa Situ, Karen Cichowski
Combinatorial strategies to target RAS-driven cancers. Nature reviews. Cancer 24 (5) (2024)
Naiara Perurena, Lisa Situ, Karen Cichowski
Combinatorial strategies to target RAS-driven cancers. Nature reviews. Cancer (2024)
Naiara Perurena, Lisa Situ, Karen Cichowski
Combinatorial strategies to target RAS-driven cancers. Nature reviews. Cancer 24 (5) (2024)
Naiara Perurena, Lisa Situ, Karen Cichowski
Combinatorial strategies to target RAS-driven cancers. Nature reviews. Cancer 24 (5) (2024)
Naiara Perurena, Lisa Situ, Karen Cichowski
Combinatorial strategies to target RAS-driven cancers. Nature reviews. Cancer 24 (5) (2024)
Abigail L Miller, Naiara Perurena, Alycia Gardner, Toshinori Hinoue, Patrick Loi, Peter W Laird, Karen Cichowski
DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer. Cancer research (2023)
Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabeth Guruceaga, Antonio Pineda-Lucena, Marta Abengózar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martínez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz Espinosa, Xabier Morales, Carlos Ortiz de Solórzano, Marta Santisteban, Luis I Ramos-García, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervás-Stubbs, Ruben Pio, María E Rodríguez-Ruiz, Carlos E de Andrea, Silvestre Vincent, Ignacio Melero Bermejo, Fernando Lecanda, Rafael Martinez-Monge
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Cancer discovery 12 (5) (2022)